Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

KindlyMD(TM) Appoints Jeremy Joyal, MD as Medical Director

Dr. Joyal, a licensed physician with board certifications in Anesthesiology, Pain Medicine, and Addiction Medicine, will oversee the Company's clinical practices and develop program protocols for pain management

SALT LAKE CITY, UT / ACCESSWIRE / August 29, 2024 / KindlyMD, Inc. ("KindlyMD" or the "Company") (NASDAQ: KDLY), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, today announced it appointed Jeremy Joyal, MD, as Medical Director, where he will oversee the Company's clinical practices while developing and implementing program protocols for pain management.

Dr. Joyal strengthens the KindlyMD leadership team by overseeing clinical practices, ensuring adherence to the Company's current standards and regulatory approach. He also assists in the development and implementation of advanced pain management programs, quality assurance, and the creation of updated policies and procedures. In addition, Dr. Joyal will play a key role in collaborating with healthcare providers and specialists to ensure comprehensive patient care is offered across the Company's platform.

Tim Pickett, PA-C, KindlyMD founder and CEO, said, "Dr. Joyal brings a wealth of expertise and a commitment to excellence that greatly enhances our clinical operations and patient care. Known for his strong connections in the interventional pain space, he is an advocate for mental health and supportive of medical cannabis treatment. We are excited to welcome Dr. Joyal and look forward to the positive impact he will have on our clinics and the patients we serve."

Dr. Joyal is a licensed physician with board certifications in Anesthesiology, Pain Medicine, and Addiction Medicine. Dr. Joyal graduated from Brigham Young University with a degree in Neuroscience in 2004 and earned his MD from the Medical College of Wisconsin. He specialized in Anesthesiology at Washington University in St. Louis, and further specialized in Pain Medicine through the University of Utah's fellowship program, graduating in 2014. He also offers medication-assisted treatment for opioid addiction.

Dr. Joyal commented, "I am thrilled to join the KindlyMD team and contribute to our shared mission of advancing patient care. My goal is to bring innovative pain management strategies with a compassionate approach to enhance our patients' well-being and overall quality of life, and I look forward to working with the KindlyMD leadership team to achieve this."

About KindlyMD
KindlyMDTM is a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies to offer patients comprehensive care and reduce the addiction and dependency of opioid use in the U.S. KindlyMD currently operates four centers including the largest alternative pain treatment center in Utah. With a focus on holistic pain management through its specialty outpatient clinical services, including, where appropriate, the recommendation of medical cannabis by KindlyMD healthcare providers, KindlyMD is providing better patient health outcomes.

For more information, please visit www.kindlymd.com.

Forward-Looking Statements
This press release contains certain forward-looking statements that are based upon current expectations and involve certain risks and uncertainties within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements can be identified by the use of words such as "should," "may," "intends," "anticipates," "believes," "estimates," "projects," "forecasts," "expects," "plans," and "proposes." These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. You are urged to carefully review and consider any cautionary statements and other disclosures, including, but not limited to, the statements made under the heading "Risk Factors" in KindlyMD, Inc.'s Annual Report on Form 10-K for the fiscal year ended December 31, 2022. KindlyMD, Inc. does not undertake any duty to update any forward-looking statements except as may be required by law. The information which appears on our websites and our social media platforms, including, but not limited to, Instagram and Facebook, is not part of this press release.

Investor Relations Contact:
Valter Pinto, Managing Director
KCSA Strategic Communications
(212) 896-1254
KindlyMD@KCSA.com

SOURCE: KindlyMD, Inc



View the original press release on accesswire.com

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.